» Articles » PMID: 25955770

"An Impediment to Living Life": Why and How Should We Measure Stiffness in Polymyalgia Rheumatica?

Overview
Journal PLoS One
Date 2015 May 9
PMID 25955770
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To explore patients' concepts of stiffness in polymyalgia rheumatica (PMR), and how they think stiffness should be measured.

Methods: Eight focus groups were held at three centres involving 50 patients with current/previous PMR. Each group had at least one facilitator and one rapporteur making field notes. An interview schedule was used to stimulate discussion. Interviews were recorded, transcribed and analysed using an inductive thematic approach.

Results: Major themes identified were: symptoms: pain, stiffness and fatigue; functional impact; impact on daily schedule; and approaches to measurement. The common subtheme for the experience of stiffness was "difficulty in moving", and usually considered as distinct from the experience of pain, albeit with a variable overlap. Some participants felt stiffness was the "overwhelming" symptom, in that it prevented them carrying out "fundamental activities" and "generally living life". Diurnal variation in stiffness was generally described in relation to the daily schedule but was not the same as stiffness severity. Some participants suggested measuring stiffness using a numeric rating scale or a Likert scale, while others felt that it was more relevant and straightforward to measure difficulty in performing everyday activities rather than about stiffness itself.

Conclusions: A conceptual model of stiffness in PMR is presented where stiffness is an important part of the patient experience and impacts on their ability to live their lives. Stiffness is closely related to function and often regarded as interchangeable with pain. From the patients' perspective, visual analogue scales measuring pain and stiffness were not the most useful method for reporting stiffness; participants preferred numerical rating scales, or assessments of function to reflect how stiffness impacts on their daily lives. Assessing function may be a pragmatic solution to difficulties in quantifying stiffness.

Citing Articles

The spectrum of giant cell arteritis through a rheumatology lens.

Khalique M, Arjunan M, Wood S, Mackie S Eye (Lond). 2024; 38(12):2437-2447.

PMID: 38898105 PMC: 11306343. DOI: 10.1038/s41433-024-03153-7.


Treatment of polymyalgia rheumatica: British Society for Rheumatology guideline scope.

Toyoda T, Armitstead Z, Bhide S, Engamba S, Henderson E, Jones C Rheumatol Adv Pract. 2024; 8(1):rkae002.

PMID: 38371294 PMC: 10871769. DOI: 10.1093/rap/rkae002.


Clinical presentation and treatment response in patients with polymyalgia rheumatica and giant cell arteritis during a 40-week follow-up.

Emamifar A, Hess S, Ellingsen T, Gerke O, Farahani Z, Hansen P Rheumatol Adv Pract. 2021; 5(3):rkab091.

PMID: 34909566 PMC: 8665449. DOI: 10.1093/rap/rkab091.


Feasibility and usefulness of a fast-track clinic for patients suspected of polymyalgia rheumatica: notes for a work schedule through a narrative review of published literature.

Hysa E, Ghorbannia A, Emamifar A, Milchert M, Manzo C Reumatologia. 2021; 59(5):323-329.

PMID: 34819707 PMC: 8609375. DOI: 10.5114/reum.2021.110600.


Not just pain and morning stiffness duration in the daily experience of patients with polymyalgia rheumatica. Does the rheumatologist listen to all patient-reported outcomes?.

Manzo C, Castagna A, Sargin B Reumatologia. 2021; 59(3):200-202.

PMID: 34538948 PMC: 8436807. DOI: 10.5114/reum.2021.106221.


References
1.
Dasgupta B, Cimmino M, Maradit-Kremers H, Schmidt W, Schirmer M, Salvarani C . 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2012; 71(4):484-92. PMC: 3298664. DOI: 10.1136/annrheumdis-2011-200329. View

2.
Spiera R, Westhovens R . Provisional diagnostic criteria for polymyalgia rheumatica: moving beyond clinical intuition?. Ann Rheum Dis. 2012; 71(4):475-6. DOI: 10.1136/annrheumdis-2011-201111. View

3.
Hewlett S, Sanderson T, May J, Alten R, Bingham 3rd C, Cross M . 'I'm hurting, I want to kill myself': rheumatoid arthritis flare is more than a high joint count--an international patient perspective on flare where medical help is sought. Rheumatology (Oxford). 2011; 51(1):69-76. DOI: 10.1093/rheumatology/keq455. View

4.
Kirwan J, Fries J, Hewlett S, Osborne R, Newman S, Ciciriello S . Patient perspective workshop: moving towards OMERACT guidelines for choosing or developing instruments to measure patient-reported outcomes. J Rheumatol. 2011; 38(8):1711-5. DOI: 10.3899/jrheum.110391. View

5.
de Wit M, Berlo S, Aanerud G, Aletaha D, Bijlsma J, Croucher L . European League Against Rheumatism recommendations for the inclusion of patient representatives in scientific projects. Ann Rheum Dis. 2011; 70(5):722-6. DOI: 10.1136/ard.2010.135129. View